WebBob Paulson has 2 current jobs as President, CEO and Director at Venture Med Group and Director at Spineology. Additionally, Bob Paulson has had 6 past jobs including President, Chief Executive Officer & Board of Directors at NxThera. WebMar 21, 2024 · Twin Cities med-tech company NxThera to be sold to Boston Scientific in $400M deal ... The new company will pursue regulatory approval of NxThera’s device as a treatment for prostate cancer, NxThera CEO Bob Paulson said. Read Article. News & Insights. News Articles; Arboretum Insights; Press Releases; Newsletter Archive; Join …
NxThera gets $1M bridge loan to continue developing
WebMar 21, 2024 · "We are excited to announce this agreement with Boston Scientific," said Bob Paulson, president and chief executive officer, NxThera. "Their strong leadership in … WebDec 21, 2016 · “We are excited about the sustained clinical and sexual health benefits out to two years for both clinicians and their patients,” said Bob Paulson, President & CEO of NxThera. gcash profitability
Bob Paulson - Wikipedia
WebJan 4, 2024 · NxThera today released three-year results from ... option that allows men suffering from BPH to resume their quality of life and preserve sexual function,” prez & CEO Bob Paulson said in a ... WebMar 21, 2024 · Updated with comments from NxThera president & CEO Bob Paulson. Boston Scientific (NYSE:BSX) said today that it laid out a $406 million deal for NxThera and its Rezūm benign prostatic hyperplasia ... WebNxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States. gcash prices